Plenity

  • Plenity 1
  • Plenity 2
  • Plenity 3
Product Description

FDA-CE cleared novel oral treatment for overweight and obesity that has an unprecedented efficacy and safety profile.

Plenity is a non-systemic medical device that complements pharmacological obesity treatments by enabling early intervention, supporting weight trajectory stabilization after systemic therapy discontinuation, and addressing patients not eligible for systemic therapy.

  • Treat earlier:  lowering the threshold for access to clinical care
  • Treat longer:  ensuring therapeutic continuity and maintenance tools
  • Treat more patients: extending the scope beyond the boundaries of systemic    therapies


Read more Show less

Gelesis srl

  • Country/Region:
    Italy
  • On CPHI since:
    2026
  • Certificates:
    4
  • Employees:
    100 - 249
Company types
Biopharmaceutical company
Pharmaceutical company
Primary activities
Biopharmaceutical
Medical Devices
OTC
Other
View company profile
Categories
more categories Show less
Specifications
  • Details
    Plenity is a CE & FDA-cleared oral medical device designed for weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m². 


  • Selling Points
    Cardiovascular Health; Digestive Health; Weight Loss Management; In RCT Plenity shows: 
    • 60% of responders lost an average 10% of their weight in 24 weeks and no overall increased risks vs placebo
    • 26% of adults with overweight or obesity were super-responders to Plenity, losing on average 14% of their weight
    • Plenity doubled the odds of achieving 5% or greater weight loss compared with placebo 
    • Pre-diabetics have 6 times the odds of achieving greater than 10% weight loss with Plenity
    • In all groups of the RCT, Plenity decreases insulin resistance including weight-loss non-responders
    • Significant improvement in LDL & TGs 
  • Model
    Oral therapy in capsule
  • Supplied from
    Italy
More specifications Fewer specifications
Sales Markets
Show more Show less

Gelesis srl

  • Country/Region:
    Italy
  • On CPHI since:
    2026
  • Certificates:
    4
  • Employees:
    100 - 249
Company types
Biopharmaceutical company
Pharmaceutical company
Primary activities
Biopharmaceutical
Medical Devices
OTC
Other
View company profile

Gelesis srl resources (1)

  • Gelesis Corporate Presentation

    Brochure Gelesis Corporate Presentation

    In this file you'll know about Gelesis and its patented platform for metabolic disease treatments, its technologies and pipeline. You will enter in the world of Plenity, an innovative oral, biomimetic medical device with unparalled safety and effectiveness profile.